SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 492 filers reported holding SEAGEN INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,667,300 | +10.2% | 22,000 | 0.0% | 0.08% | +25.0% |
| Q2 2023 | $4,234,120 | -7.9% | 22,000 | -3.1% | 0.06% | -10.4% |
| Q1 2023 | $4,596,069 | +58.1% | 22,700 | +0.3% | 0.07% | +71.8% |
| Q4 2022 | $2,907,667 | -50.5% | 22,626 | -47.3% | 0.04% | -53.6% |
| Q3 2022 | $5,874,000 | -32.8% | 42,926 | -13.1% | 0.08% | -32.3% |
| Q2 2022 | $8,737,000 | +20.3% | 49,376 | -2.0% | 0.12% | +47.6% |
| Q1 2022 | $7,260,000 | +2.1% | 50,400 | +9.6% | 0.08% | +15.1% |
| Q4 2021 | $7,112,000 | -21.6% | 46,000 | -13.9% | 0.07% | -20.7% |
| Q3 2021 | $9,067,000 | +108.8% | 53,400 | +94.2% | 0.09% | +119.0% |
| Q2 2021 | $4,342,000 | -11.4% | 27,500 | -22.1% | 0.04% | -19.2% |
| Q1 2021 | $4,902,000 | -39.9% | 35,300 | -24.2% | 0.05% | -44.1% |
| Q4 2020 | $8,162,000 | – | 46,600 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |